PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 28 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $157,937 | -36.3% | 28,052,730 | +2.9% | 0.93% | -9.8% |
| Q1 2022 | $248,128 | -54.1% | 27,266,721 | +3.3% | 1.04% | -36.6% |
| Q4 2021 | $540,158 | -7.0% | 26,400,703 | +16.1% | 1.63% | +17.1% |
| Q3 2021 | $580,999 | -18.9% | 22,739,675 | +11.0% | 1.40% | +4.7% |
| Q2 2021 | $716,238 | +0.9% | 20,481,486 | -3.8% | 1.33% | -5.4% |
| Q1 2021 | $709,543 | -4.0% | 21,301,191 | -25.3% | 1.41% | -28.4% |
| Q4 2020 | $739,410 | +277.5% | 28,504,629 | +43.6% | 1.97% | +69.3% |
| Q3 2020 | $195,868 | +589.7% | 19,844,780 | +141.1% | 1.16% | +281.0% |
| Q2 2020 | $28,399 | +121.3% | 8,231,492 | +96.3% | 0.30% | -4.7% |
| Q1 2020 | $12,831 | +65.4% | 4,193,059 | +177.8% | 0.32% | +63.3% |
| Q4 2019 | $7,758 | +98.7% | 1,509,414 | +99.4% | 0.20% | +130.6% |
| Q3 2019 | $3,905 | – | 756,797 | – | 0.08% | – |
| Q2 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $4 | -100.0% | 590 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $42,125 | +87.7% | 7,786,485 | +23.2% | 1.27% | +54.9% |
| Q2 2018 | $22,441 | +155.5% | 6,321,293 | +47.5% | 0.82% | +88.5% |
| Q1 2018 | $8,784 | +1454.7% | 4,284,697 | +1903.0% | 0.44% | +868.9% |
| Q4 2017 | $565 | – | 213,917 | – | 0.04% | – |
Download | ||||||